| Literature DB >> 35222072 |
Marine Van Hollebeke1,2, Diego Poddighe1,2, Beatrix Clerckx2, Jan Muller2, Greet Hermans2,3, Rik Gosselink1,2, Daniel Langer1,2, Zafeiris Louvaris1,2.
Abstract
BACKGROUND: Critically ill patients who have difficulties weaning from the mechanical ventilator are prone to develop respiratory muscle weakness. Inspiratory muscle training (IMT) can improve respiratory muscle strength. Whether IMT can improve scalene and sternocleidomastoid muscle oxygenation parameters is unknown. AIM: To compare changes in muscle oxygenation parameters of scalene and sternocleidomastoid inspiratory muscles during a standardized task between patients with weaning difficulties who received either high-intensity IMT (intervention) or sham low-intensity IMT (control).Entities:
Keywords: cell respiration; intensive care unit; metabolism; near-infrared spectroscopy; respiratory muscle training; respiratory muscles; ventilator weaning
Year: 2022 PMID: 35222072 PMCID: PMC8864155 DOI: 10.3389/fphys.2022.786575
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
FIGURE 1Experimental design. After randomization patients were familiarized during one or two training sessions with the high-intensity inspiratory muscle training (IMT) or sham low-intensity IMT training protocol, in respect to the allocated training group. The subsequent day and the day after the successful separation attempt or after 28 days after inclusion, the patients in both groups performed a standardized loaded breathing task with an external load of approximately 30% of the maximal inspiratory pressure (PImax) of the patient at baseline. IMT was continued until weaning success or failure.
FIGURE 2Typical calculation of muscle oxygen saturation index (%StiO2) during a loaded breathing set. Baseline %StiO2 (defined as the average of the last 10 s before the initiation of each breathing set), Mean %StiO2 (defined as the average of the last two breaths of each set) and Nadir %StiO2 (defined as the lowest value recorded during the last two breaths of each set). Numbers (from 1 to 8) represent the number of breaths of the set. %StiO2 data depict the sternocleidomastoid muscle. %StiO2 changes from baseline are calculated as follow: Mean-Baseline = −3.8% and Nadir– Baseline = −6.3%.
FIGURE 3Flowchart of all patients who were screened for eligibility for the study.
Baseline characteristics.
| Intervention, high-intensity IMT ( | Control, sham low-intensity IMT ( | ||
|
|
| ||
| Mean | Mean | ||
| Sex (male/female), | 13/9 | 9/10 | 0.54 |
| Age, years | 52 ± 18 | 64 ± 7 | 0.01 |
| Heigth, cm | 170 ± 11 | 170 ± 8 | 0.91 |
| Weight, kg | 72 ± 21 | 67 ± 17 | 0.40 |
| BMI | 24.7 ± 5.9 | 23.1 ± 5.1 | 0.35 |
| Admitted to, | |||
| Surgical ICU | 17 | 17 | |
| Medical ICU | 5 | 2 | |
| Diagnosis, | |||
| Transplantation | 14 | 9 | |
| Lung | 11 | 9 | |
| Lung and kidney | 1 | 0 | |
| Lung and liver | 1 | 0 | |
| Liver and kidney | 1 | 0 | |
| Lung volume reduction surgery | 0 | 1 | |
| Pneumonia | 4 | 2 | |
| Cardiac failure | 2 | 3 | |
| Hematologic | 1 | 0 | |
| Esophageal surgery | 0 | 1 | |
| Maxillofacial surgery | 1 | 0 | |
| Polytrauma | 0 | 1 | |
| Organophosphate intoxication | 0 | 1 | |
| COPD, | 3 | 4 | 0.68 |
| APACHE-II score, /60 | 19 ± 8 | 20 ± 6 | 0.87 |
| Start IMT, ET-tube/cannula | 5/17 | 1/18 | 0.19 |
| PImax, cmH2O | 32 ± 12 | 35 ± 11 | 0.67 |
| %pred. | 33 ± 13 | 41 ± 15 | 0.18 |
| FVC, liter | 0.83 ± 0.29 | 1.00 ± 0.34 | 0.35 |
| %pred. | 22 ± 7 | 31 ± 12 | 0.01 |
| Peak inspiratory flow, L/s | 0.98 ± 0.29 | 1.04 ± 0.25 | 0.57 |
| MV before 1st SA, days | 17 ± 24 | 9 ± 8 | 0.21 |
| MV before start IMT, days | 26 ± 24 | 27 ± 15 | 0.87 |
| Ventilator support at inclusion | |||
| Ventilator mode, | |||
| CPAP | 16 | 15 | |
| BIPAP | 1 | 1 | |
| NAVA | 4 | 1 | |
| FiO2, % | 28 ± 9 | 31 ± 9 | 0.25 |
| PEEP, cmH2O | 6 ± 1 | 5 ± 1 | 0.09 |
| PS, cmH2O | 8 ± 4 | 7 ± 3 | 0.60 |
| NAVA level, cmH2O/μV | 1.0 ± 0.2 | 3 |
IMT, inspiratory muscle training; BMI, body mass index; ICU, intensive care unit; COPD, chronic obstructive pulmonary disease; APACHE-II score, severity-of-disease classification; IMT, inspiratory muscle training; ET-tube, endotracheal tube; PImax, maximal inspiratory pressure; FVC, forced vital capacity; MV, mechanical ventilation; SA, separation attempt,; CPAP, continuous positive airway pressure; BIPAP, bi-level positive airway pressure; NAVA, neurally adjusted ventilator assist; FiO
Training data and breathing characteristics during the first and last inspiratory muscle training session.
|
|
|
| |||||||
|
|
| ||||||||
|
|
|
| |||||||
| Training days | 15 ± 7 | 15 ± 4 | 0.79 | ||||||
| Completed/planned sessions (%) | 74 ± 15 | 75 ± 15 | 0.94 | ||||||
| Total training volume, joules | 274.6 ± 219.5 | 81.6 ± 45.1 | <0.01 | ||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
|
|
| |||||||
|
|
| ||||||||
|
|
|
|
|
|
|
|
|
| |
|
| |||||||||
| Training load, cmH2O | 11.0 ± 4.4 | 19.4 ± 7.7 | 8.4 | 5.5; 11.3 | 2.7 ± 0.8 | 2.7 ± 0.8 | 0 | 0; 0 | <0.01 |
| Training load, %PImax | 34 ± 5 | 62 ± 22 | 29 | 19; 38 | 8 ± 3 | 8 ± 3 | 0 | 0; 0 | <0.01 |
| Mean inspiratory flow, L/sec | 0.45 ± 0.32 | 0.50 ± 0.27 | 0.05 | −0.06; 0.15 | 0.51 ± 0.18 | 0.52 ± 0.18 | 0.02 | −0.07; 0.11 | 0.81 |
| Peak inspiratory flow, L/sec | 0.92 ± 0.45 | 1.06 ± 0.45 | 0.14 | −0.03; 0.30 | 0.87 ± 0.26 | 0.88 ± 0.27 | 0.01 | −0.11; 0.13 | 0.29 |
| Tidal volume, L | 0.52 ± 0.32 | 0.65 ± 0.35 | 0.13 | 0.00; 0.26 | 0.47 ± 0.19 | 0.68 ± 0.36 | 0.21 | 0.08; 0.34 | 0.63 |
| Tidal volume, %FVC | 61 ± 27 | 58 ± 30 | −3 | −18; 12 | 51 ± 18 | 67 ± 29 | 15 | −1; 30 | 0.22 |
| Number of breaths | 28 ± 7 | 26 ± 6 | −2 | −5; 1 | 27 ± 5 | 27 ± 4 | 0 | −3; 2 | 0.70 |
| Work of breathing/session, joules | 14.5 ± 15.1 | 28.5 ± 24.7 | 14.1 | 4.8; 23.3 | 5.0 ± 2.6 | 7.3 ± 4.9 | 2.3 | −8.1; 12.8 | <0.01 |
| Mean power of breathing, watts | 0.41 ± 0.32 | 0.78 ± 0.55 | 0.37 | 0.19; 0.56 | 0.20 ± 0.10 | 0.20 ± 0.10 | 0.01 | −0.03; 0.04 | <0.01 |
| Peak power of breathing, watts | 0.98 ± 0.72 | 2.07 ± 1.42 | 1.08 | 0.60; 1.57 | 0.35 ± 0.17 | 0.35 ± 0.16 | 0.00 | −0.05; 0.05 | <0.01 |
| Perceived dyspnea, MBS, /10 | 5 ± 2 | 4 ± 2 | −2 | −2; −1 | 5 ± 2 | 3 ± 2 | −2 | −3; −1 | 0.65 |
| Perceived respiratory effort, MBS, /10 | 6 ± 2 | 4 ± 2 | −1 | −2; 0 | 5 ± 2 | 3 ± 1 | −2 | −3; −1 | 0.05 |
| Unpleasantness, VAS, /10 | 3 ± 3 | 3 ± 3 | 0 | −1.7; 1.2 | 4 ± 2 | 3 ± 2 | −1 | −2; 1 | 0.54 |
Breathing characteristics during the first and the last inspiratory muscle training session are depicted with within and between group comparisons. Last session missing for 1 patient in the control group. IMT, inspiratory muscle training; total training volume, the overall work of breathing performed over the whole course of the inspiratory muscle training period; PImax, maximal inspiratory pressure; FVC, forced vital capacity; %FVC, tidal volume expressed as the percentage of the baseline measurement for the first session and the post FVC measurement for the last session; MBS, modified BORG scale; VAS, visual analog scale; SD, standard deviation; CI, confidence interval. *Significance level: p-value < 0.05.
Respiratory muscle function and pulmonary function before (pre) and after (post) IMT.
| Intervention group, high-intensity IMT ( | Control group, sham low-intensity IMT ( | Between group comparison | |||||||
|
|
| ||||||||
| Pre | Post | Estimated mean difference (post–pre) | Pre | Post | Estimated mean difference (post–pre) | Multivariate effect | |||
| Mean | Mean | Mean | 95%CI | Mean | Mean | Mean | 95%CI | ||
| Maximal inspiratory pressure, cmH2O | 32 ± 12 | 47 ± 15 | 15 | 7; 24 | 353 ± 11 | 48 ± 17 | 13 | 4; 23 | 0.77 |
| Maximal inspiratory pressure, %pred. | 32 ± 14 | 47 ± 15 | 15 | 6; 24 | 40 ± 15 | 53 ± 19 | 14 | 4; 15 | 0.31 |
| Forced vital capacity, L | 0.83 ± 0.29 | 1.16 ± 0.48 | 0.33 | 0.07; 0.59 | 0.99 ± 0.35 | 1.09 ± 0.50 | 0.13 | −0.15; 0.41 | 0.08 |
| Forced vital capacity, %pred | 22 ± 7 | 30 ± 9 | 8 | 1; 15 | 31 ± 13 | 32 ± 14 | 3 | −5; 10 | 0.03 |
| Peak inspiratory flow, L/s | 0.98 ± 0.29 | 1.33 ± 0.48 | 0.36 | 0.14; 0.57 | 1.04 ± 0.25 | 1.13 ± 0.29 | 0.08 | −0.16; 0.32 | 0.06 |
Respiratory muscle function measured before (pre) and after (post) the inspiratory muscle training period. Post measurement missing for 1 patient in the control group. IMT, inspiratory muscle training; %pred, percent of the predicted value of the maximal inspiratory pressure; SD, standard deviation; CI, confidence interval. *Significance level: p-value < 0.05.
Breathing characteristics, hemodynamic responses and symptoms during the sandardized loaded breathing tasks.
|
|
|
| |||||||
|
|
| ||||||||
|
|
|
| |||||||
|
|
| ||||||||
| Inspiratory load, cmH2O | 12 ± 5 | 12 ± 4 | 0.83 | ||||||
| Inspiratory load, % PImax | 37 ± 10 | 34 ± 9 | 0.30 | ||||||
|
| |||||||||
|
|
|
|
|
|
|
| |||
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
| |
|
| |||||||||
|
| |||||||||
| 0 ± 15 | 1 ± 6 | 1 | −6; 9 | 2 ± 4 | 2 ± 4 | 0 | −2; 6 | 0.67 | |
| Δ Mean arterial pressure, mmHg | 6 ± 7 | −2 ± 5 | −8 | −12; −4 | 2 ± 9 | −5 ± 10 | −7 | −15; −1 | 0.33 |
| Δ Respiratory rate, breaths/min | 1 ± 8 | 1 ± 7 | 1 | −3; 4 | 3 ± 5 | 2 ± 9 | 0 | −5; 5 | 0.85 |
| Δ Oxygen saturation, % | −1 ± 3 | 0 ± 3 | 1 | −1; 4 | −1 ± 2 | −1 ± 3 | 0 | −2; 2 | 0.58 |
|
| |||||||||
| Mean inspiratory pressure, cmH2O | 8.4 ± 3.4 | 8.6 ± 3.0 | 0.1 | −0.6; 0.9 | 7.8 ± 1.6 | 7.6 ± 1.8 | −0.2 | −0.6; 0.3 | 0.51 |
| Mean inspiratory flow, L/sec | 0.40 ± 0.22 | 0.62 ± 0.32 | 0.22 | 0.12; 0.33 | 0.35 ± 0.20 | 0.49 ± 0.14 | 0.14 | 0.05; 0.23 | 0.29 |
| Peak inspiratory flow, L/sec | 0.90 ± 0.42 | 1.14 ± 0.51 | 0.23 | 0.1; 0.38 | 0.76 ± 0.36 | 0.96 ± 0.24 | 0.19 | 0.1; 0.33 | 0.42 |
| Tidal volume, L | 0.49 ± 0.28 | 0.68 ± 0.31 | 0.19 | 0.1; 0.3 | 0.39 ± 0.21 | 0.65 ± 0.30 | 0.26 | 0.1; 0.41 | 0.47 |
| Tidal volume, %FVC at baseline | 59 ± 26 | 87 ± 44 | 28 | 12; 43 | 48 ± 30 | 74 ± 46 | 26 | 10; 43 | 0.46 |
| Number of breaths | 25 ± 9 | 24 ± 5 | −1 | −5; 3 | 23 ± 8 | 23 ± 7 | 0 | −4; 3 | 0.75 |
| Total work of breathing, joules | 14.3 ± 15.2 | 16.8 ± 12.9 | 2.6 | −2.0; 7.2 | 8.3 ± 6.0 | 14.2 ± 10.5 | 5.9 | 1.6; 10.2 | 0.30 |
| Work of breathing/breath, joules | 0.53 ± 0.45 | 0.70 ± 0.51 | 0.17 | 0.04; 0.30 | 0.35 ± 0.22 | 0.57 ± 0.30 | 0.22 | 0.10; 0.35 | 0.32 |
| Mean power of breathing, watts | 0.42 ± 0.33 | 0.63 ± 0.51 | 0.21 | 0.06; 0.43 | 0.31 ± 0.20 | 0.40 ± 0.17 | 0.09 | −0.14; 0.30 | 0.24 |
| Peak power of breathing, watts | 1.11 ± 0.83 | 1.46 ± 1.07 | 0.35 | 0.10; 0.60 | 0.79 ± 0.49 | 0.99 ± 0.43 | 0.20 | −0.34; 0.74 | 0.25 |
|
| |||||||||
| Perceived dyspnea, MBS, /10 | 4 ± 2 | 3 ± 2 | −1 | −2; 0 | 5 ± 2 | 4 ± 2 | −1 | −2; 0 | 0.65 |
| Perceived respiratory effort, MBS, /10 | 5 ± 2 | 4 ± 2 | −1 | −2; 0 | 5 ± 2 | 4 ± 1 | −1 | −2; 0 | 0.59 |
| Unpleasantness, VAS, /10 | 4 ± 2 | 3 ± 3 | −1 | −3; 0 | 4 ± 3 | 3 ± 1 | −1 | −2; 0 | 0.89 |
Patients in both groups performed a loaded breathing task at the initiation (pre) and the end (post) of the inspiratory muscle training period. Data of posttest missing for two patients in the control group. Hemodynamic and respiratory responses to the loaded breathing task are expressed as the difference between rest value before the initiation of the loaded breathing task and the value at the end of the loaded breathing task. Data of the pre and post measurement are presented with the difference between the post measurement and the pre measurement. Arterial oxygen saturation was measured by a pulse oximetry. IMT, inspiratory muscle training; SD, standard deviation; CI, confidence interval; MAP, mean arterial blood pressure; RR, respiratory rate; Pinsp., inspiratory pressure; insp., inspiratory; Vt, tidal volume; FVC, forced vital capacity; WoB, work of breathing; PoB, power of breathing; MBS, modified BORG scale; VAS, visual analog scale. *Significance level: p-value < 0.05.
Changes in inspiratory muscles oxygenation parameters during the standardized loaded breathing tasks.
| Intervention group | Control group | Between group comparison | |||||||
|
|
| ||||||||
| Pre | Post | Estimated mean difference (post–pre) | Pre | Post | Estimated mean difference (post–pre) | Multivariate effect | |||
| Mean | Mean | Mean | 95%CI | Mean | Mean | Mean | 95%CI | ||
|
| |||||||||
| 1.9 ± 5.5 | 6.6 ± 5.4 | +4.7 | 1,6; 7,9 | 4.0 ± 4.0 | 5.6 ± 5.0 | +1.7 | −1.8; 5.2 | 0.28 | |
| 2.8 ± 3.9 | 6.5 ± 6.4 | +3.7 | 0.7; 6.7 | 4.7 ± 4.1 | 5.3 ± 3.9 | +0.7 | −2.7; 4.0 | 0.22 | |
| 4.6 ± 9.2 | 13.0 ± 11.1 | +8.4 | 2.5; 14.2 | 8.4 ± 7.6 | 10.9 ± 8.6 | +2.5 | −4.0; 9.0 | 0.24 | |
| −3.2 ± 2.4 | −1.6 ± 1.9 | +1.5 | −0.3; 3.3 | −3.5 ± 3.7 | −3.1 ± 3.6 | +0.4 | −1.6; 2.5 | 0.30 | |
| −4.0 ± 3.5 | −2.3 ± 1.8 | +1.8 | 0.1; 3.5 | −4.1 ± 2.4 | −3.5 ± 2.8 | +0.6 | −1.3; 2.5 | 0.30 | |
| −15.1 ± 13.8 | −6.9 ± 6.4 | +8.3 | 0.9; 15.6 | −18.4 ± 15.4 | −10.2 ± 8.2 | +8.2 | 0.1; 16.3 | 0.41 | |
|
| |||||||||
| 2.8 ± 4.6 | 2.9 ± 3.3 | +0.1 | −2.8; 3.0 | 3.6 ± 5.9 | 3.6 ± 4.8 | +0.0 | −3.3; 3.4 | 0.73 | |
| 4.2 ± 3.9 | 3.5 ± 3.7 | −0.8 | −3.2; 1.6 | 4.6 ± 4.4 | 4.5 ± 3.2 | −0.2 | −2.9; 2.6 | 0.67 | |
| 7.1 ± 6.9 | 6.4 ± 6.3 | −0.7 | −5.4; 4.0 | 8.1 ± 9.7 | 8.1 ± 7.4 | 0.0 | −5.4; 5.5 | 0.72 | |
| −4.4 ± 4.2 | −2.5 ± 3.0 | +1.8 | −0.6; 4.3 | −4.5 ± 4.0 | −5.2 ± 4.3 | −0.7 | −3.5; 2.2 | 0.09 | |
| −5.7 ± 6.1 | −3.4 ± 3.2 | +2.3 | −0.6; 5.2 | −5.7 ± 4.5 | −6.7 ± 4.1 | −1.0 | −4.3; 2.4 | 0.02 | |
| −27.9 ± 55.2 | −9.6 ± 12.1 | +18.4 | −1.4; 38.1 | −21.0 ± 13.2 | −17.3 ± 10.4 | +3.7 | −18.7; 26.0 | < 0.01 | |
Changes from rest of scalene and sternocleidomastoid muscles in oxygenation parameters during the standard loaded breathing task at the initiation (pre) and end (post) of the inspiratory muscle training period. Data of posttest missing in one patient in the intervention group and two patients in the control group. Oxygenated [Hb + Mb], oxygenated hemoglobin and myoglobin; deoxygenated [Hb + Mb], deoxygenated hemoglobin and myoglobin; total [Hb + Mb], total hemoglobin and myoglobin; StiO